GLASDEGIB vs GLOFITAMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
GLASDEGIB vs GLOFITAMAB: Safety Overview
| Metric | GLASDEGIB | GLOFITAMAB |
|---|---|---|
| Total FAERS Reports | 521 | 1,116 |
| Deaths Reported | 196 | 315 |
| Death Rate | 37.6% | 28.2% |
| Hospitalizations | 275 | 492 |
| Average Patient Age | 67.4 yrs | 62.5 yrs |
| % Female Patients | 38.6% | 53.2% |
| FDA Approval Date | Nov 21, 2018 | N/A |
| Manufacturer | Pfizer Laboratories Div Pfizer Inc | Genentech, Inc. |
| Route | ORAL | INTRAVENOUS |
| Marketing Status | Prescription | N/A |